Cargando…

Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy

Induction of antigen-specific immune activation by the maturation of dendritic cells (DCs) is a strategy used for cancer immunotherapy. In this study, we find that FimH, which is an Escherichia coli adhesion portion, induces toll-like receptor 4-dependent and myeloid differentiation protein 2-indepe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Xu, Li, Park, Hae-Bin, Hwang, Juyoung, Kwak, Minseok, Lee, Peter C. W., Liang, Guang, Zhang, Xiaoyan, Xu, Jianqing, Jin, Jun-O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055316/ https://www.ncbi.nlm.nih.gov/pubmed/32132528 http://dx.doi.org/10.1038/s41467-020-15030-4

Ejemplares similares

Escherichia coli adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4
por: Zhang, Wei, et al.
Publicado: (2023)

Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations
por: Feenstra, T., et al.
Publicado: (2016)

Selection for nonspecific adhesion is a driver of FimH evolution increasing Escherichia coli biofilm capacity
por: Yoshida, Mari, et al.
Publicado: (2022)

Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran
por: Asadi, Karam MR, et al.
Publicado: (2012)

Transcriptional Response Of E. coli Upon FimH-mediated Fimbrial Adhesion
por: Bhomkar, Prasanna, et al.
Publicado: (2010)

D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic Escherichia coli
por: Montes-Robledo, Alfredo, et al.
Publicado: (2021)

The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes
por: Bouckaert, Julie, et al.
Publicado: (2006)

The FimH Gene in Uropathogenic Escherichia coli Strains Isolated From Patients With Urinary Tract Infection
por: Hojati, Zohreh, et al.
Publicado: (2015)

FimH and Type 1 Pili Mediated Tumor Cell Cytotoxicity by Uropathogenic Escherichia coli In Vitro
por: Van Eyssen, Shelly Roselyn, et al.
Publicado: (2023)

FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens
por: Sarshar, Meysam, et al.
Publicado: (2020)

Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists
por: Mousavifar, Leila, et al.
Publicado: (2023)

Evaluation of accessible regions of Escherichia coli fimH mRNA through computational prediction and experimental investigation
por: Mood, Elnaz Harifi, et al.
Publicado: (2021)

Bacterial Lectin FimH and Its Aggregation Hot-Spots: An Alternative Strategy against Uropathogenic Escherichia coli
por: Nasi, Georgia I., et al.
Publicado: (2023)

Catch-bond mechanism of the bacterial adhesin FimH
por: Sauer, Maximilian M., et al.
Publicado: (2016)

FimH as a scaffold for regulated molecular recognition
por: Ludwig, Shivani Gupta, et al.
Publicado: (2021)

Comparative Study of Aryl O-, C-, and S-Mannopyranosides as Potential Adhesion Inhibitors toward Uropathogenic E. coli FimH
por: Mousavifar, Leila, et al.
Publicado: (2019)

Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist
por: Spaulding, Caitlin N., et al.
Publicado: (2017)

CRISPRi Induced Suppression of Fimbriae Gene (fimH) of a Uropathogenic Escherichia coli: An Approach to Inhibit Microbial Biofilms
por: Zuberi, Azna, et al.
Publicado: (2017)

Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli
por: Russell, Colin W., et al.
Publicado: (2018)

d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications
por: Scribano, Daniela, et al.
Publicado: (2020)

Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin
por: de Ruyck, Jerome, et al.
Publicado: (2016)

En route to photoaffinity labeling of the bacterial lectin FimH
por: Lindhorst, Thisbe K, et al.
Publicado: (2010)

Diazirine-functionalized mannosides for photoaffinity labeling: trouble with FimH
por: Beiroth, Femke, et al.
Publicado: (2018)

FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
por: Zhang, Yang, et al.
Publicado: (2022)

Point Mutations in FimH Adhesin of Crohn's Disease-Associated Adherent-Invasive Escherichia coli Enhance Intestinal Inflammatory Response
por: Dreux, Nicolas, et al.
Publicado: (2013)

Mutation of Tyr137 of the universal Escherichia coli fimbrial adhesin FimH relaxes the tyrosine gate prior to mannose binding
por: Rabbani, Said, et al.
Publicado: (2017)

FimH-based display of functional eukaryotic proteins on bacteria surfaces
por: Chmielewski, Markus, et al.
Publicado: (2019)

Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation—The Example of FimH
por: Krammer, Eva-Maria, et al.
Publicado: (2018)

Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli
por: Kisiela, Dagmara I., et al.
Publicado: (2015)

Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin
por: Touaibia, Mohamed, et al.
Publicado: (2017)

Are D-manno-configured Amadori products ligands of the bacterial lectin FimH?
por: Gloe, Tobias-Elias, et al.
Publicado: (2015)

A Novel Integrated Way for Deciphering the Glycan Code for the FimH Lectin
por: Dumych, Tetiana, et al.
Publicado: (2018)

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn’s disease
por: Chevalier, Grégoire, et al.
Publicado: (2021)

Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions
por: Kalas, Vasilios, et al.
Publicado: (2017)

Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH–Oligomannose-3 Complex
por: Wellens, Adinda, et al.
Publicado: (2008)

In silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infections
por: Habibi, Mehri, et al.
Publicado: (2015)

Conserved FimH mutations in the global Escherichia coli ST131 multi-drug resistant lineage weaken interdomain interactions and alter adhesin function
por: Qin, Jilong, et al.
Publicado: (2022)

A bivalent glycopeptide to target two putative carbohydrate binding sites on FimH
por: Lindhorst, Thisbe K, et al.
Publicado: (2010)

Synthesis and testing of the first azobenzene mannobioside as photoswitchable ligand for the bacterial lectin FimH
por: Chandrasekaran, Vijayanand, et al.
Publicado: (2013)

Correction: Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH–Oligomannose-3 Complex
por: Wellens, Adinda, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_tmep2bidcttaf7n5pogvgpb8b2